Breakthrough research conducted at our Lindner Research Center is making heart valve replacement without open heart surgery available to patients who would otherwise not be candidates for this revolutionary procedure. In early April, we were the first facility in the country to perform this innovative procedure on a low surgical risk patient. 

In the past only elderly patients considered to be at high risk for open heart surgery were eligible for a Transcatheter Aortic Valve Replacement (TAVR), a highly-effective catheter-based valve replacement procedure that our physicians have pioneered.
​
Now, research conducted by our cardiovascular experts has opened TAVR to a new and broader group of patients, those considered to be at low risk for open heart surgery. We are the only facility in the region and one of few programs in the country to offer this revolutionary heart procedure to lower-risk surgical candidates. 

“Based on our leading edge research on heart valve treatment, local patients can benefit from this new procedure and be treated long before it becomes available for general use at other local hospitals,” Dean Kereiakes, M.D, medical director of The Christ Hospital Heart and Vascular Center and The Lindner Research Center at The Christ Hospital, said. “Research performed at The Christ Hospital will hopefully make this life-saving, minimally invasive technology an option for all heart patients.”